Clinical Trial Update: Immune Monitoring Protocol in Men With Prostate Cancer Enrolled in a Clinical Trial of Sipuleucel-T

View source ↗

Summary

Clinical trial update detailing immune monitoring protocol for men with prostate cancer in a sipuleucel-T study; trial status terminated with results posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• sipuleucel-T (sipuleucel-T)

Snippet

Sponsor: Dendreon | Conditions: Prostate Cancer | Status: TERMINATED | Results posted: 2019-08-19